International Clinical Trial: Prospective, Single-Center, Single-Arm Clinical Study of Ivosidenib (AK112) Combined with Chemotherapy for Neoadjuvant Treatment of Locally Advanced Oral Squamous Cell Carcinoma

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117076) titled 'Prospective, Single-Center, Single-Arm Clinical Study of Ivosidenib (AK112) Combined with Chemotherapy for Neoadjuvant Treatment of Locally Advanced Oral Squamous Cell Carcinoma' on Jan. 19.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The first affiliated hostipal of nanchang university

Condition: oral squamous cell carcinoma

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-01-20

Target Sample Size: experimental group:15;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=306709

Disclaimer: Curate...